Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-24-002015
Filing Date
2024-10-22
Accepted
2024-10-22 21:12:33
Documents
1
Period of Report
2024-10-18

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 4598
  Complete submission text file 0000897069-24-002015.txt   6220
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10500 UNIVERSITY CENTER DRIVE SUITE 110 TAMPA FL 33612
Business Address
Yamashita Dennis (Reporting) CIK: 0002039412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 241387625